High-Dose Cyclophosphamide in Highly Refractory Multiple Myeloma Patients As a Bridge to Further Novel Therapies

被引：3
|
作者：
Nikonova, Anna [1 ]
Caplan, Stephen N. [2 ]
Shamy, April [2 ]
Gyger, Martin [2 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5676.5676
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5676
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Zver, Samo
    Zadnik, Vesna
    Bunc, Matjaz
    Rogel, Polona
    Cernelc, Peter
    Kozelj, Mirta
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (05) : 408 - 414
  • [42] DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma
    Yuen, Hiu Lam Agnes
    Low, Michael Sze Yuan
    Fedele, Pasquale
    Kalff, Anna
    Walker, Patricia
    Bergin, Krystal
    Coutsouvelis, John
    Grigoriadis, George
    Spencer, Andrew
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2842 - 2846
  • [43] STEM CELL MOBILIZATION EFFICIENCY OF HIGH DOSE CYCLOPHOSPHAMIDE COMPARED TO INTERMEDIATE DOSE CYCLOPHOSPHAMIDE IN MULTIPLE MYELOMA PATIENTS
    Colasante, F.
    Schiavo, D.
    Ferreri, A.
    Rinaldi, C.
    Savignano, C.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 135 - 135
  • [44] On-demand plerixafor added to high-dose cyclophosphamide and pegfilgrastim in the mobilization of patients with multiple myeloma: high effectiveness and affordable cost
    Hou, Liqiong
    Li, Juan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S116 - S117
  • [45] HIGH-DOSE CYCLOPHOSPHAMIDE, BCNU AND VP-16 WITH AUTOLOGOUS BLOOD STEM-CELL SUPPORT FOR REFRACTORY MULTIPLE-MYELOMA
    VENTURA, GJ
    BARLOGIE, B
    HESTER, JP
    YAU, JC
    LEMAISTRE, CF
    WALLERSTEIN, RO
    SPINOLO, JA
    DICKE, KA
    HORWITZ, LH
    ALEXANIAN, R
    BONE MARROW TRANSPLANTATION, 1990, 5 (04) : 265 - 268
  • [46] Effective mobilization of stem cells in multiple myeloma following priming by high-dose cyclophosphamide and bortezomib
    Reti, M.
    Mikala, G.
    Goda, V.
    Janosi, J.
    Peto, M.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S90 - S90
  • [47] High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies
    Lin, PT
    Martin, BA
    Weinacker, AB
    So, YT
    MUSCLE & NERVE, 2006, 33 (03) : 433 - 435
  • [48] ASCT and high-dose melphalan in multiple myeloma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (11): : E481 - E481
  • [49] High-dose chemotherapy in multiple myeloma - Reply
    Attal, M
    Harousseau, JL
    Bataille, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24): : 1845 - 1845
  • [50] Collection of peripheral blood progenitor cells (PBPC) in patients with multiple myeloma (MM) after high-dose cyclophosphamide (HDCYC).
    Mant, G
    Thiessard, F
    Faberes, C
    ConyMakhoul, P
    Boiron, JM
    Pigneux, A
    Vezon, G
    Bernard, P
    Broustet, A
    Salmi, R
    Reiffers, J
    BLOOD, 1996, 88 (10) : 3681 - 3681
12345